These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5559087)

  • 1. Sodium transfer to cerebrospinal fluid in functional psychiatric illness.
    Baker EF
    Can Psychiatr Assoc J; 1971 Apr; 16(2):167-70. PubMed ID: 5559087
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients.
    Bowers MB; Heninger GR; Gerbode F
    Int J Neuropharmacol; 1969 May; 8(3):255-62. PubMed ID: 5796265
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.
    Verbanck PM; Lotstra F; Gilles C; Linkowski P; Mendlewicz J; Vanderhaeghen JJ
    Life Sci; 1984 Jan; 34(1):67-72. PubMed ID: 6694511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of baseline and drug-induced levels of cyclic nucleotides in the cerebrospinal fluid of control and psychiatric patients.
    Smith CC; Tallman JF; Post RM; van Kammen DP; Jimerson DC; Brown GL
    Life Sci; 1976 Jul; 19(1):131-6. PubMed ID: 940431
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between central monoaminergic systems: dopamine-serotonin.
    Roccatagliata G; Albano C; Cocito L; Maffini M
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.
    Ashcroft GW; Crawford TB; Eccleston D; Sharman DF; MacDougall EJ; Stanton JB; Binns JK
    Lancet; 1966 Nov; 2(7472):1049-52. PubMed ID: 4162505
    [No Abstract]   [Full Text] [Related]  

  • 7. Central noradrenergic function in man: vanillylmandelic acid in CSF.
    Jimerson DC; Gordon EK; Post RM; Goodwin FK
    Brain Res; 1975 Dec; 99(2):434-9. PubMed ID: 1182564
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients.
    Gerner RH; Yamada T
    Brain Res; 1982 Apr; 238(1):298-302. PubMed ID: 6123376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein pattern of cerebrospinal fluid in mental disease.
    Dencker SJ; Malm U
    Acta Psychiatr Scand Suppl; 1968; 203():105-9. PubMed ID: 4177807
    [No Abstract]   [Full Text] [Related]  

  • 10. A method of analyzing sodium-22 retention as determined by whole-body counting: a useful clinical tool.
    Baer L; Bartko JJ
    Exp Med Surg; 1968 Mar; 26(3):144-51. PubMed ID: 5735315
    [No Abstract]   [Full Text] [Related]  

  • 11. Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid.
    Anderson GM; Gerner RH; Cohen DJ; Fairbanks L
    Biol Psychiatry; 1984 Oct; 19(10):1427-35. PubMed ID: 6518200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium transfer to cerebrospinal fluid in functional psychiatric illness.
    Furlong FW
    Can Psychiatr Assoc J; 1971 Aug; 16(4):379. PubMed ID: 5119824
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.
    Sørensen PS; Gjerris A; Hammer M
    J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):50-7. PubMed ID: 3973621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium transfer from plasma to CSF in severe depressive illness.
    Carroll BJ; Steven L; Pope RA; Davies B
    Arch Gen Psychiatry; 1969 Jul; 21(1):77-81. PubMed ID: 5793683
    [No Abstract]   [Full Text] [Related]  

  • 15. Central norepinephrine metabolism in affective illness: MHPG in the cerebrospinal fluid.
    Post RM; Gordon EK; Goodwin FK; Bunney WE
    Science; 1973 Mar; 179(4077):1002-3. PubMed ID: 4687583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal-fluid neuropeptides: a biochemical subgrouping approach.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Neuropsychobiology; 1992; 26(1-2):37-42. PubMed ID: 1361969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals.
    Gerner RH; Merrill JE
    Biol Psychiatry; 1983 May; 18(5):565-9. PubMed ID: 6860728
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
    Bowers MB; Study RE
    Psychopharmacology (Berl); 1979 Mar; 62(1):17-22. PubMed ID: 220657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
    Csernansky JG; Faull KF; Pfefferbaum A
    Psychiatry Res; 1988 Sep; 25(3):361-3. PubMed ID: 2460883
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of monoamine metabolites in human cerebrospinal fluid to age.
    Bowers MB; Gerbode FA
    Nature; 1968 Sep; 219(5160):1256-7. PubMed ID: 5677419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.